Circulating thymus and activation-regulated chemokine/CC chemokine ligand 17 is a strong candidate diagnostic marker for interstitial lung disease in patients with malignant tumors: a result from a pilot study

Hiromichi YamaneDepartment of General Internal Medicine 4, Kawasaki Medical School, Kita-ku, Okayama, JapanCorrespondence[email protected]

Nobuaki OchiDepartment of General Internal Medicine 4, Kawasaki Medical School, Kita-ku, Okayama, Japan

Tomoko YamagishiDepartment of General Internal Medicine 4, Kawasaki Medical School, Kita-ku, Okayama, Japan

Yoshihiro HondaDepartment of General Internal Medicine 4, Kawasaki Medical School, Kita-ku, Okayama, Japan

Masami TakeyamaDepartment of General Internal Medicine 4, Kawasaki Medical School, Kita-ku, Okayama, Japan

Nagio TakigawaDepartment of General Internal Medicine 4, Kawasaki Medical School, Kita-ku, Okayama, Japan

Pages 949-959 | Published online: 17 Jun 2015

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

SaitoYGemmaACurrent status of DILD in molecular targeted therapiesInt J Clin Oncol201217653454123152005
PubMed Web of Science ®Google Scholar
CamusPKudohSEbinaMInterstitial lung disease associated with drug therapyBr J Cancer2004912S18S2315340374
PubMedGoogle Scholar
HottaKKiuraKTakigawaNComparison of the incidence and pattern of interstitial lung disease during erlotinib and gefitinib treatment in Japanese patients with non-small cell lung cancer: the Okayama Lung Cancer Study Group experienceJ Thorac Oncol20105217918420101144
PubMed Web of Science ®Google Scholar
SametJMDoes idiopathic pulmonary fibrosis increase lung cancer risk?Am J Respir Crit Care Med201016111210619788
PubMedGoogle Scholar
ShahDJSachsRKWilsonDJRadiation-induced cancer: a modern viewBr J Radiol201285102011661173
PubMed Web of Science ®Google Scholar
KohnoNKyoizumiSAwayaYFukuharaHYamakidoMAkiyamaMNew serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6Chest198996168732661160
PubMed Web of Science ®Google Scholar
TakahashiHKurokiYTanakaHSerum levels of surfactant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosisAm J Respir Crit Care Med2000162125826310903251
PubMed Web of Science ®Google Scholar
GreeneKEKingTEJrKurokiYSerum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosisEur Respir J200219343944611936520
PubMed Web of Science ®Google Scholar
SakamotoKTaniguchiHKondohYSerum KL-6 in fibrotic NSIP: correlations with physiologic and radiologic parametersRespir Med2010104112713319811899
PubMed Web of Science ®Google Scholar
OhnishiHYokoyamaAKondoKComparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseasesAm J Respir Crit Care Med2002165337838111818324
PubMed Web of Science ®Google Scholar
TanakaSHattoriNIshikawaNKrebs von den Lungen-6 (KL-6) is a prognostic biomarker in patients with surgically resected non-small cell lung cancerInt J Cancer2012130237738721351094
PubMed Web of Science ®Google Scholar
MiyazakiENurekiSFukamiTElevated levels of thymus and activation-regulated chemokine in bronchoalveolar lavage fluid from patients with eosinophilic pneumoniaAm J Respir Crit Care Med200216581125113111956056
PubMed Web of Science ®Google Scholar
MiyazakiENurekiSOnoECirculating thymus and activation-regulated chemokine/CCL17 is a useful biomarker for discriminating acute eosinophilic pneumonia from other causes of acute lung injuryChest200713161726173417565019
PubMed Web of Science ®Google Scholar
JonesKVariFKeaneCSerum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphomaClin Cancer Res201319373174223224400
PubMed Web of Science ®Google Scholar
BelperioJADyMMurrayLThe role of the Th2 CC chemokine ligand CCL17 in pulmonary fibrosisJ Immunol200417374692469815383605
PubMed Web of Science ®Google Scholar
American Thoracic SocietyIdiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statementAm J Respir Crit Care Med20001612pt164666410673212
PubMedGoogle Scholar
KakinumaTWakugawaMNakamuraKHinoHMatsushimaKTamakiKHigh level of thymus and activation-regulated chemokine in blister fluid and sera of patients with bullous pemphigoidBr J Dermatol2003148220321012588369
PubMed Web of Science ®Google Scholar
IshikawaNHattoriNYokoyamaAKohnoNUtility of KL-6/MUC1 in the clinical management of interstitial lung diseasesRespir Investig2012501313
PubMedGoogle Scholar
ShielsMSChaturvediAKKatkiHAGochuicoBRCaporasoNEEngelsEACirculating markers of interstitial lung disease and subsequent risk of lung cancerCancer Epidemiol Biomarkers Prev201120102262227221828236
PubMed Web of Science ®Google Scholar
FujiwaraYKiuraKToyookaSElevated serum level of sialylated glycoprotein KL-6 predicts a poor prognosis in patients with non-small cell lung cancer treated with gefitinibLung Cancer2008591818717765355
PubMed Web of Science ®Google Scholar
KobayashiHKanohSMotoyoshiKSerum surfactant protein-A, but not surfactant protein-D or KL-6, can predict preclinical lung damage induced by smokingBiomarkers200813438539218595202
PubMed Web of Science ®Google Scholar
Feghali-BostwickCATsaiCGValentineVGCellular and humoral autoreactivity in idiopathic pulmonary fibrosisJ Immunol200717942592259917675522
PubMed Web of Science ®Google Scholar
ZuoFKaminskiNEuguiEGene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humansProc Natl Acad Sci U S A20029996292629711983918
PubMed Web of Science ®Google Scholar
KurosuKTakiguchiYOkadaOIdentification of annexin 1 as a novel autoantigen in acute exacerbation of idiopathic pulmonary fibrosisJ Immunol2008181175676718566442
PubMed Web of Science ®Google Scholar
BorchersATChangCKeenCLGershwinMEIdiopathic pulmonary fibrosis an epidemiological and pathological reviewClin Rev Allergy Immunol201140211713420838937
PubMed Web of Science ®Google Scholar
WallaceWARamageEALambDHowieSEA type 2 (Th2-like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA)Clin Exp Immunol199510134364417664490
PubMed Web of Science ®Google Scholar
KawashimaTTadaYAsanoYSerum TARC/CCL17 levels are increased in dermatomyositis associated with interstitial lung diseaseJ Dermatol Sci2010601525420800454
PubMed Web of Science ®Google Scholar
SaekiHTamakiKThymus and activation regulated chemokine (TARC)/CCL17 and skin diseasesJ Dermatol Sci2006432758416859899
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Circulating thymus and activation-regulated chemokine/CC chemokine ligand 17 is a strong candidate diagnostic marker for interstitial lung disease in patients with malignant tumors: a result from a pilot study

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Circulating thymus and activation-regulated chemokine/CC chemokine ligand 17 is a strong candidate diagnostic marker for interstitial lung disease in patients with malignant tumors: a result from a pilot study

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date